Bank of America’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$93.7K Sell
103,312
-57,661
-36% -$52.3K ﹤0.01% 5564
2025
Q1
$72.6K Buy
160,973
+122,858
+322% +$55.4K ﹤0.01% 5632
2024
Q4
$19.1K Sell
38,115
-1,334,307
-97% -$670K ﹤0.01% 5950
2024
Q3
$1.24M Buy
1,372,422
+11,497
+0.8% +$10.4K ﹤0.01% 4157
2024
Q2
$1.36M Buy
1,360,925
+49,644
+4% +$49.5K ﹤0.01% 4005
2024
Q1
$1.94M Buy
1,311,281
+1,287,428
+5,397% +$1.91M ﹤0.01% 3759
2023
Q4
$26K Buy
23,853
+17,449
+272% +$19K ﹤0.01% 5796
2023
Q3
$7.56K Sell
6,404
-65,806
-91% -$77.7K ﹤0.01% 6000
2023
Q2
$102K Sell
72,210
-1,371,569
-95% -$1.93M ﹤0.01% 5349
2023
Q1
$2.17M Buy
1,443,779
+1,442,750
+140,209% +$2.16M ﹤0.01% 3657
2022
Q4
$1.2K Buy
1,029
+22
+2% +$26 ﹤0.01% 6492
2022
Q3
$1K Sell
1,007
-9,993
-91% -$9.92K ﹤0.01% 6795
2022
Q2
$18K Hold
11,000
﹤0.01% 6397
2022
Q1
$17K Sell
11,000
-24,243
-69% -$37.5K ﹤0.01% 6771
2021
Q4
$86K Buy
35,243
+23,651
+204% +$57.7K ﹤0.01% 6109
2021
Q3
$29K Sell
11,592
-5,837
-33% -$14.6K ﹤0.01% 6377
2021
Q2
$49K Sell
17,429
-10,592
-38% -$29.8K ﹤0.01% 6029
2021
Q1
$66K Buy
28,021
+15,057
+116% +$35.5K ﹤0.01% 5852
2020
Q4
$23K Hold
12,964
﹤0.01% 5790
2020
Q3
$12K Sell
12,964
-153,643
-92% -$142K ﹤0.01% 5742
2020
Q2
$145K Buy
166,607
+150,568
+939% +$131K ﹤0.01% 4912
2020
Q1
$13K Sell
16,039
-9,431
-37% -$7.64K ﹤0.01% 5676
2019
Q4
$23K Sell
25,470
-15,335
-38% -$13.8K ﹤0.01% 5633
2019
Q3
$39K Sell
40,805
-19,895
-33% -$19K ﹤0.01% 5566
2019
Q2
$67K Buy
60,700
+3,621
+6% +$4K ﹤0.01% 5410
2019
Q1
$74K Buy
57,079
+15,389
+37% +$20K ﹤0.01% 5274
2018
Q4
$38K Sell
41,690
-41,125
-50% -$37.5K ﹤0.01% 5542
2018
Q3
$171K Buy
82,815
+34,473
+71% +$71.2K ﹤0.01% 4864
2018
Q2
$87K Sell
48,342
-15,332
-24% -$27.6K ﹤0.01% 5145
2018
Q1
$150K Buy
63,674
+23,974
+60% +$56.5K ﹤0.01% 4817
2017
Q4
$74K Buy
39,700
+23,159
+140% +$43.2K ﹤0.01% 5099
2017
Q3
$41K Sell
16,541
-9,088
-35% -$22.5K ﹤0.01% 5220
2017
Q2
$71K Buy
25,629
+2,812
+12% +$7.79K ﹤0.01% 4993
2017
Q1
$69K Buy
22,817
+2,785
+14% +$8.42K ﹤0.01% 5055
2016
Q4
$63K Buy
20,032
+9,154
+84% +$28.8K ﹤0.01% 5064
2016
Q3
$37K Sell
10,878
-27,457
-72% -$93.4K ﹤0.01% 5091
2016
Q2
$87K Buy
38,335
+3,925
+11% +$8.91K ﹤0.01% 4801
2016
Q1
$86K Sell
34,410
-6,315
-16% -$15.8K ﹤0.01% 4753
2015
Q4
$135K Buy
40,725
+2,530
+7% +$8.39K ﹤0.01% 4655
2015
Q3
$92K Sell
38,195
-22,980
-38% -$55.4K ﹤0.01% 4724
2015
Q2
$179K Buy
61,175
+19,586
+47% +$57.3K ﹤0.01% 4342
2015
Q1
$167K Sell
41,589
-11,374
-21% -$45.7K ﹤0.01% 4123
2014
Q4
$160K Buy
52,963
+10,995
+26% +$33.2K ﹤0.01% 4279
2014
Q3
$106K Sell
41,968
-902
-2% -$2.28K ﹤0.01% 4461
2014
Q2
$106K Buy
42,870
+35,706
+498% +$88.3K ﹤0.01% 4594
2014
Q1
$19K Sell
7,164
-1,215
-15% -$3.22K ﹤0.01% 5133
2013
Q4
$25K Buy
8,379
+742
+10% +$2.21K ﹤0.01% 5126
2013
Q3
$24K Sell
7,637
-3,332
-30% -$10.5K ﹤0.01% 5024
2013
Q2
$35K Buy
+10,969
New +$35K ﹤0.01% 5179